{Reference Type}: Case Reports
{Title}: Hydralazine-induced vasculitis presenting with ocular manifestations.
{Author}: Hawn VS;Vo TA;Flomenbaum D;Gibralter RP;
{Journal}: Am J Ophthalmol Case Rep
{Volume}: 26
{Issue}: 0
{Year}: Jun 2022
暂无{DOI}: 10.1016/j.ajoc.2022.101515
{Abstract}: <B>UNASSIGNED: </B>The objective of the study is to report a case of ocular manifestations in a patient with hydralazine-induced vasculitis.<BR><B>UNASSIGNED: </B>An 88-year-old female was admitted for lower gastrointestinal bleeding. Nine days after admission, she developed bilateral conjunctival chemosis and injection, which rapidly progressed into grouped blistering eruptions of the periorbital skin, face, and neck. After extensive testing and evaluation, her constellation of findings was diagnosed as hydralazine-induced vasculitis. Treatment with intravenous steroids and discontinuation of hydralazine resulted in improvement of the cutaneous and ocular manifestations. Herein we describe the clinical course of an adult patient with symptoms and signs consistent with hydralazine-induced vasculitis to highlight that ophthalmological manifestations can be the first symptoms in patients with life-threatening dermatological conditions.<BR><B>UNASSIGNED: </B>To our knowledge, this report is the first case of hydralazine-induced vasculitis initially presenting with ocular manifestations.